VativoRx’s senior management counts more than 100 years combined in pharmacy operations and pharmacy benefits management.
Lisa Quarterman, Chief Executive Officer, Managing Partner
Lisa has overseen pharmacy benefit management (PBM) programs for patients, TPAs and self-insured organizations since 1993. In 2001, she founded Cypress Care, the first PBM to serve patients receiving benefits under major insurers’ workers’ compensation programs. In 2005, she was named winner of the RX Benefit Innovation Award by the Pharmacy Benefit Management Institute for “innovative solutions to problems surrounding drug benefit programs.” In 2006, she was a finalist nominee for the Stevie Awards for Women in Business, and in 2007, listed among the "2007 Women to Watch" by Business Insurance magazine.
As chief executive officer of Cypress Care, Lisa implemented PBM programs for large self-insured organizations, including the California State Insurance Fund, and like funds in Georgia and Florida, as well as for county governments and municipalities. She developed and managed PBM plans for major insurers, including Zurich, Coventry and Liberty Mutual.
Valerie Verkholaz, Managing Partner
Valerie is a founding member of VativoRx and oversees VativoRx vendor relationships. As buyer and procurement director for PharmaLife, she manages relationships with more than 50 vendors, PhramaLife’s VA contracts and pharmacist staffing.
Valerie holds a degree in Biology from San Francisco State University and a Masters in Healthcare Management from Brenau University.
Michael Bogachek, Chief Operating Officer
Recognizing the need for a PBM service for middle-market, government and quasi-government entities, Michael led the team to concept and establish VativoRx, and as chief operating officer, oversees the development of new products and services for VativoRx pharmacy services to VativoRx clients.
As chief operating officer of PharmaLife, Michael oversees the operations of the 20-year-old privately held retail, wholesale, LTC, government contract and private facility pharmacy business that provides products and services to a wide range of public and private organizations.
Michael is Aids Drug Assistance Program Certified and a member of the Center for Disease Control’s Advisory Board on HIV testing. He holds a B.S. in Industrial and Systems Engineering from Georgia Institute of Technology and a Ph.D. in Bio-Engineering from Moscow Humanitarian University. He is a member of the Independent Pharmacists of America.
Melvin D. Johnson, Chief Financial Officer
As chief financial officer, Melvin is responsible for VativoRx’s daily financial operations, including overseeing the firm’s client contracts. He brings more than three decades of experience as Contract Administrator of federal government services contracting firms, including Atlanta-based GSE Facility Services, MEI Services and Pharmasouth Government Services. He is an experienced proposal writer and examiner, and has administered government contracts in excess of $100 million.
Melvin is an alumnus of the George Washington University School of Contracting and studied chemistry at Paine College and Georgia State University. He is a member of the National Bookkeepers and National Executive Housekeepers Associations.
Tatyana Livitina, Director of Operations
As director of operations for VativoRx, Tatyana oversees company compliance with the State Board of Pharmacy, Center for Medicare and Medicaid Services (CMS) and other federal and state regulations. She supervises pharmacy and DME claims processing, client eligibility verification, participation clarification and prior authorization procedures. She works directly with our clients to ensure customer satisfaction, including assisting with enrollment and coverage issues and resolving claims.
Tatyana holds a B.S. in Computer Engineering from the Kursk Polytechnic Institute in Kursk, Russia, where she developed scientific software applications. She is a certified pharmacy technician and a member of the Cambridge Who’s Who and National Association of Professional Women.